Myriad Genetics (MYGN)

Myriad Genetics (MYGN) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• MYGN last traded at $5.92, -6.77% on the day.
• Myriad Genetics: market cap $607.38M, P/E -5.0, revenue $806.60M over the last four quarters, next earnings 2026-11-04.
• Over the past year MYGN returned -25.53%; year to date -3.74%.

Updated 2026-11-02 18:00 UTC